Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0020672 (
hypothermia
)
17,327
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mild
hypothermia
renders potent neuroprotection against acute brain injury. Recent reports show that adenosine 5'-monophosphate (AMP) plays a role in thermoregulation and induces
hypothermia
in mice. Therefore, this study sought to determine whether AMP induces
hypothermia
in rats and to study its collective effects on cerebral ischemia induced by 2-h middle cerebral artery occlusion. An intraperitoneal injection of AMP induced
hypothermia
dose-dependently. At the dose of 4 mmol/kg, AMP induced promising mild
hypothermia
for 2.5 h. Unexpectedly, the AMP-induced
hypothermia
failed to reduce infarct volume after brain ischemia; instead, it exaggerated the ischemic damage, indicated by an increased infarct volume, as well as increased incidences of hemorrhagic transformation, seizure, and animal death. Physiologic parameter monitoring revealed that AMP causes profound hypotension, leading to cerebral hypoperfusion. Furthermore, AMP administration resulted in severe hyperglycemia, metabolic acidosis, and hypocalcemia. In addition, western blots showed early dephosphorylation and degradation of
AMP-activated kinase
in the ischemic cortex in AMP-treated rats. Taken together, our findings suggest that AMP induces
hypothermia
in rats, probably by limiting cellular access to glucose. However, the potential neuroprotection of AMP-mediated
hypothermia
against ischemia was overwhelmed by the detrimental effects of hypotension and hyperglycemia, thus making AMP an unlikely agent for inducing
hypothermia
to protect the brain against ischemic injury.
...
PMID:When hypothermia meets hypotension and hyperglycemia: the diverse effects of adenosine 5'-monophosphate on cerebral ischemia in rats. 1931 49